EdgarLookup

4D Molecular Therapeutics, Inc. — 3 Filings

26 3 filings on record

This page lists all 3 filings submitted to the SEC by 4D Molecular Therapeutics, Inc. (FDMT), sorted by most recent first. Each row links to the full filing on EdgarLookup. 4D Molecular Therapeutics, Inc. has filed 26 3 documents with the SEC since 2015. To view all SEC filings by 4D Molecular Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 144/A 3 3/A 4 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A EFFECT FWP POS AM POSASR RW S-1 S-1/A S-1MEF S-3 S-3ASR S-8 S-8 POS SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
3 3 0001193125-26-006805 Jan 7, 2026 Jan 5, 2026
3 3 0001193125-25-326864 Dec 19, 2025 Dec 9, 2025
3 3 0001193125-25-315962 Dec 11, 2025 Dec 9, 2025
3 3 0000950130-25-000195 Oct 10, 2025 Sep 30, 2025
3 0001415889-24-027636 Nov 25, 2024 Nov 13, 2024
3 OWNERSHIP DOCUMENT 0000921895-24-001663 Aug 1, 2024 Jul 22, 2024
3 FORM 3 0001567619-23-007285 Sep 26, 2023 Sep 22, 2023
3 FORM 3 0001567619-23-005526 Apr 5, 2023 Mar 24, 2023
3 FORM 3 0001567619-22-017845 Sep 27, 2022 Sep 23, 2022
3 OWNERSHIP DOCUMENT 0000921895-22-002106 Jun 27, 2022 Jun 16, 2022
3 FORM 3 0001567619-22-007790 Mar 31, 2022 Mar 21, 2022
3 FORM 3 0001567619-21-011945 Jun 9, 2021 Jun 7, 2021
3 FORM 3 0001567619-20-020931 Dec 10, 2020
3 OWNERSHIP DOCUMENT 0001387131-20-010839 Dec 10, 2020
3 FORM 3 0001567619-20-020897 Dec 10, 2020
3 FORM 3 0001567619-20-020896 Dec 10, 2020
3 FORM 3 0001567619-20-020895 Dec 10, 2020
3 FORM 3 0001567619-20-020894 Dec 10, 2020
3 FORM 3 0001567619-20-020893 Dec 10, 2020
3 FORM 3 0001567619-20-020892 Dec 10, 2020
3 FORM 3 0001567619-20-020891 Dec 10, 2020
3 FORM 3 0001567619-20-020889 Dec 10, 2020
3 FORM 3 0001567619-20-020887 Dec 10, 2020
3 FORM 3 0001567619-20-020886 Dec 10, 2020
3 FORM 3 0001567619-20-020885 Dec 10, 2020
3 FORM 3 0001567619-20-020884 Dec 10, 2020